SpineGuard announces its 2025 fiscal calendar by Investing.com

PARIS AND BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News:

SpineGuard (FR0011464452) ALSGD, an innovative company that uses DSG ® (Dynamic Surgical Guidance) local conduction sensing technology to secure and simplify orthopedic implant placement, today announced its 2025 financial information release schedule.

Fiscal calendar 2025

Note (): Press releases are published after the stock market closes. This information is subject to change.

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jerome and Stephane Piet, SpineGuard is an innovative company that uses its proprietary radiation-free real-time sensing technology DSG ® (Dynamic Surgical Guidance) to secure and simplify the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices incorporating its technology. More than 100,000 surgeries worldwide have been secured thanks to DSG ® and 34 studies published in peer-reviewed scientific journals have shown the multiple benefits that DSG ® offers to patients, surgeons, surgical staff and hospitals. Building on these strong fundamentals and several strategic partnerships, SpineGuard is expanding its DSG ® technology to treat scoliosis via anterior approach, sacroiliac joint fusion, dental implants and innovations such as the “smart” pedicle screw, power drill or surgical procedures. Robots. DSG ® was co-invented by Maurice Bourillon, PhD, Ciaran Bolger, MD, and Alain Vanquathem, biomedical engineer. SpineGuard has been involved in numerous environmental, social and governance (ESG) initiatives.

For more information, visit www.spineguard.com

Disclaimer

SpineGuard's securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any United States securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an advertisement and not a prospectus, and the information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of the securities referred to herein in the United States where such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

View source version on Businesswire.com: https://www.businesswire.com/news/home/20250103107539/en/

SpineGuard
Pierre Jerome
CEO and Chairman of the Board of Directors
Tel: +33 1 45 18 45 19
p.jerome@spineguard.com

SpineGuard
Anne Charlotte Millard
CFO
Tel: 01 45 18 45 19
ac.millard@spineguard.com

newcap
Investor relations and financial communications
Mathilde Bohen / Aurélie Manafarire
Tel: +33 1 44 71 94 94
spinguard@newcap.eu

Source: Spainguard